top of page

U.S. Patent on Smoking Cessation Therapy Investment and Manufacturing Opportunity

Listing Code:

XYMF1I

State:

Not Disclosed

Category:

Medical Devices & Manufacturers

Asking Price:

-

Revenue:

-

XYMF1I
Company Overview American Healthcare Capital is pleased to exclusively represent the Sale of a U.S. patent for a Smoking Cessation therapy product. People who smoke, as well as those who are exposed to second-hand smoke, develop a range of potentially fatal diseases such as a variety of cancers, coronary and cardiovascular diseases leading to heart attacks and stroke, chronic obstructive pulmonary disease (COPD), and immune suppression. These are all due to depleted micronutrients and antioxidants in the body. By replenishing depleted micronutrients and antioxidants with the patented formulation, the morbidity and mortality rates are significantly decreased, there are improvements in numerous biomarkers, and people are given a fighting chance to stay well and live longer. Financial Overview The global cessation products market was estimated at $24 Billion in 2022 and is expected to reach $57 Billion by 2023, showing a CAGR rate of 9.2%. The holder of this Patent for a smoking cessation therapy product is a well-recognized wellness physician. He is seeking a strategic partner and a financial sponsor to help manufacture his patented formulation in various forms, such as tablets, capsules, drops, and lozenges, to help market this product initially in the U.S., and to finally make it available for global distribution. He is open to all deal structures, including the sale of his U.S. Patent and earning perpetual royalties. Asking Price The Asking Price is to be determined.

Inquire About This Listing:

In order to learn more about our listing, you must:

1. Complete a Buyer Profile:

This profile will be used to pre-qualify buyers and determine whether we can share additional details about our listings. If you have already completed a Buyer Profile, disregard.

YOU ONLY NEED TO COMPLETE A BUYER PROFILE ONCE. 

2. Sign NDA with Listing Code:

To learn more about this listing, you must sign an NDA. When completing the NDA, you will need to copy the exact LISTING CODE and LISTING TITLE.

Listing Code:

XYMF1I

Listing Title:

U.S. Patent on Smoking Cessation Therapy Investment and Manufacturing Opportunity

Heading 4

Contact the Team

Jack Eskenazi American Healthcare Capital

Jack Eskenazi

President/Founder

American HealthCare Capital

Dr. Allen Nazeri DDS MBA.jpg

Dr. Allen Nazeri 

Managing Partner

PRIME exits

bottom of page